​
​

Predictive Oncology Ownership 2024 | Who Owns Predictive Oncology Now?

OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

0.00%

Insider Ownership

2.16%

Retail Ownership

97.83%

Institutional Holders

1.00

Predictive Oncology Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISORNET FINANCIAL, INC0.00%-95--99Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC--1--1Jun 30, 2024

Predictive Oncology's largest institutional shareholder is ADVISORNET FINANCIAL, INC, holding 0.00% of the company's total share outstanding, currently valued at $99.00. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISORNET FINANCIAL, INC0.00%-95--99Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC--1--1Jun 30, 2024

The largest Predictive Oncology shareholder by % of total assets is ADVISORNET FINANCIAL, INC. The company owns 95.00 shares of Predictive Oncology (POAI), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORNERSTONE PLANNING GROUP LLC--1--1Jun 30, 2024
ADVISORNET FINANCIAL, INC0.00%-95--99Jun 30, 2024

As of Jun 30 2024, Predictive Oncology's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased 0.00 stocks of POAI, valued at $1.00.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISORNET FINANCIAL, INC0.00%-95--99Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC--1--1Jun 30, 2024

As of Jun 30 2024, Predictive Oncology's biggest institutional seller is ADVISORNET FINANCIAL, INC. The company sold 0.00 shares of POAI, valued at $99.00.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Predictive Oncology Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
T. Rowe Price Index Trust, Inc.0.01%227,900--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%2,099,534--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%610,794--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%55,193--Feb 29, 2024
USAA MUTUAL FUNDS TRUST0.00%8,381--Jan 31, 2024
EQ ADVISORS TRUST0.00%13,207--Mar 31, 2024
Dimensional ETF Trust0.00%2,0582,058-Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%410--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%617617-Jan 31, 2024

Predictive Oncology's largest mutual fund holder by % of total assets is "T. Rowe Price Index Trust, Inc.", owning 227.90K shares, compromising 0.01% of its total assets.

Predictive Oncology Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 241-50.00%
31 Mar, 242-
31 Dec, 232-
30 Sep, 232-
30 Jun, 232-90.91%
31 Mar, 2322-29.03%
31 Dec, 223124.00%
30 Sep, 2225-7.41%
30 Jun, 2227-
31 Mar, 222735.00%
31 Dec, 2120-
30 Sep, 2120-4.76%
30 Jun, 2121-4.55%
31 Mar, 2122214.29%
31 Dec, 207-
30 Sep, 207-46.15%
30 Jun, 2013160.00%
31 Mar, 205-
31 Dec, 195-

As of 30 Jun 24, 1 institutions are holding Predictive Oncology's shares, representing a decrease of -50.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2495-1.04%
31 Mar, 2496-
31 Dec, 2396-99.08%
30 Sep, 2310,453-
30 Jun, 2310,453-99.76%
31 Mar, 234,440,465-4.17%
31 Dec, 224,633,4563.22%
30 Sep, 224,488,908-0.96%
30 Jun, 224,532,57311.69%
31 Mar, 224,057,999-0.63%
31 Dec, 214,083,92416.68%
30 Sep, 213,499,9609.97%
30 Jun, 213,182,587-17.38%
31 Mar, 213,852,094747.06%
31 Dec, 20454,76328.67%
30 Sep, 20353,435-66.83%
30 Jun, 201,065,582247.72%
31 Mar, 20306,4501074.41%
31 Dec, 1926,094-

Predictive Oncology (POAI) has 95.00 shares outstanding as of 30 Jun 24, down -1.04% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 240.00%40745.83%
31 Mar, 240.00%41837.50%
31 Dec, 230.00%3.48%
30 Sep, 230.26%376.96%
30 Jun, 230.26%0.00%
31 Mar, 23111.90%0.82%
31 Dec, 22116.77%0.89%
30 Sep, 22114.54%0.66%
30 Jun, 22131.58%0.87%
31 Mar, 22123.28%0.56%
31 Dec, 21148.84%0.91%
30 Sep, 21127.56%0.95%
30 Jun, 21115.99%0.59%
31 Mar, 21140.39%51.11%
31 Dec, 2016.57%9.99%
30 Sep, 2012.88%0.85%
30 Jun, 2038.84%31.13%
31 Mar, 2011.17%1234.92%
31 Dec, 190.95%-

As of 30 Jun 24, Predictive Oncology is held by 0.00% institutional shareholders, representing a 40745.83% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24--
31 Mar, 24--100.00%
31 Dec, 231-
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 2310-23.08%
31 Dec, 221385.71%
30 Sep, 227-46.15%
30 Jun, 2213-7.14%
31 Mar, 221455.56%
31 Dec, 219-30.77%
30 Sep, 2113-7.14%
30 Jun, 2114-30.00%
31 Mar, 2120300.00%
31 Dec, 20525.00%
30 Sep, 204-66.67%
30 Jun, 2012200.00%
31 Mar, 204-20.00%
31 Dec, 195-

- institutional shareholders have increased their position in POAI stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--100.00%
30 Jun, 232100.00%
31 Mar, 231-85.71%
31 Dec, 227250.00%
30 Sep, 222-50.00%
30 Jun, 224-
31 Mar, 224300.00%
31 Dec, 211-50.00%
30 Sep, 212-33.33%
30 Jun, 21350.00%
31 Mar, 212-
31 Dec, 20--100.00%
30 Sep, 203200.00%
30 Jun, 201-
31 Mar, 201-
31 Dec, 19--

- institutional shareholders have reduced their position in POAI stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 241-50.00%95-1.04%0.00%40745.83%----
31 Mar, 242-96-0.00%41837.50%--100.00%--
31 Dec, 232-96-99.08%0.00%3.48%1---
30 Sep, 232-10,453-0.26%376.96%----100.00%
30 Jun, 232-90.91%10,453-99.76%0.26%0.00%--100.00%2100.00%
31 Mar, 2322-29.03%4,440,465-4.17%111.90%0.82%10-23.08%1-85.71%
31 Dec, 223124.00%4,633,4563.22%116.77%0.89%1385.71%7250.00%
30 Sep, 2225-7.41%4,488,908-0.96%114.54%0.66%7-46.15%2-50.00%
30 Jun, 2227-4,532,57311.69%131.58%0.87%13-7.14%4-
31 Mar, 222735.00%4,057,999-0.63%123.28%0.56%1455.56%4300.00%
31 Dec, 2120-4,083,92416.68%148.84%0.91%9-30.77%1-50.00%
30 Sep, 2120-4.76%3,499,9609.97%127.56%0.95%13-7.14%2-33.33%
30 Jun, 2121-4.55%3,182,587-17.38%115.99%0.59%14-30.00%350.00%
31 Mar, 2122214.29%3,852,094747.06%140.39%51.11%20300.00%2-
31 Dec, 207-454,76328.67%16.57%9.99%525.00%--100.00%
30 Sep, 207-46.15%353,435-66.83%12.88%0.85%4-66.67%3200.00%
30 Jun, 2013160.00%1,065,582247.72%38.84%31.13%12200.00%1-
31 Mar, 205-306,4501074.41%11.17%1234.92%4-20.00%1-
31 Dec, 195-26,094-0.95%-5---

Predictive Oncology Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 27, 2023Nuzum Charles Lee Srdirector-S-SaleSell10,000$3.04$30.39K24,033

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 27, 2023MYERS ROBERT Lofficer CHIEF FINANCIAL OFFICERF-InKindSell510$2.96$1.51K4,720
Sep 27, 2023Nuzum Charles Lee Srdirector-S-SaleSell10,000$3.04$30.39K24,033

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 12, 2024ST. CLAIR GREGORY SRdirector-A-AwardBuy3,268--22,534
Apr 12, 2024Hawryluk Matthewdirector-A-AwardBuy2,368--9,488
Apr 12, 2024Rao Veenadirector-A-AwardBuy3,268--9,117
Apr 12, 2024Nuzum Charles Lee Srdirector-A-AwardBuy3,268--31,921
Apr 12, 2024HANDLEY DANIEL Edirector-A-AwardBuy2,353--18,661
Apr 12, 2024CHUNG-WELCH NANCYdirector-A-AwardBuy2,353--21,237
Oct 04, 2023Rao Veenadirector-A-AwardBuy1,875--5,849
Oct 04, 2023HANDLEY DANIEL Edirector-A-AwardBuy1,875--14,665
Oct 04, 2023ST. CLAIR GREGORY SRdirector-A-AwardBuy1,875--17,934
Oct 04, 2023CHUNG-WELCH NANCYdirector-A-AwardBuy1,875--16,960
Oct 04, 2023Hawryluk Matthewdirector-A-AwardBuy1,875--7,135
Oct 04, 2023Nuzum Charles Lee Srdirector-A-AwardBuy2,605--26,638
Sep 27, 2023MYERS ROBERT Lofficer CHIEF FINANCIAL OFFICERM-ExemptBuy1,667--5,230
Sep 27, 2023MYERS ROBERT Lofficer CHIEF FINANCIAL OFFICERF-InKindSell510$2.96$1.51K4,720
Sep 27, 2023Nuzum Charles Lee Srdirector-S-SaleSell10,000$3.04$30.39K24,033
Jul 05, 2023Nuzum Charles Lee Srdirector-A-AwardBuy3,773--34,033
Jul 05, 2023ST. CLAIR GREGORY SRdirector-A-AwardBuy3,773--16,059
Jul 05, 2023Rao Veenadirector-A-AwardBuy2,675--3,974
Jul 05, 2023Hawryluk Matthewdirector-A-AwardBuy2,675--5,260
Jul 05, 2023HANDLEY DANIEL Edirector-A-AwardBuy2,675--12,790

The last insider sell of Predictive Oncology's stock was made by MYERS ROBERT L on Sep 27 2023, selling 510 shares at $2.96 per share (valued at $1.51K).

Predictive Oncology Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 20236--
Q3 202372350.00%
Q2 20237--
Q1 202381800.00%
Q4 202213--
Q3 20226--
Q2 20225--
Q1 202213--
Q4 20217--
Q3 202183266.67%
Q2 202171700.00%
Q1 20212--
Q4 202071700.00%
Q3 20203925156.00%
Q2 20201211200.00%
Q1 202083266.67%
Q4 20195--
Q3 201920--
Q2 20192212200.00%
Q1 201913--

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Predictive Oncology's insiders, as of Q4 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2023---
Q3 2023-1-
Q2 2023---
Q1 2023---
Q4 20225--
Q3 2022---
Q2 20225--
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021---
Q4 2020-1-
Q3 20203--
Q2 2020---
Q1 2020---
Q4 2019---
Q3 20193--
Q2 20192--
Q1 20192--

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Predictive Oncology's stocks.

Predictive Oncology Peer Ownership

TickerCompany
ZJYLJin Medical International Ltd.
GMVDG Medical Innovations Holdings Ltd
GCTKGlucoTrack, Inc.
MBOTMicrobot Medical Inc.
BNGOBionano Genomics, Inc.
ISRGIntuitive Surgical, Inc.
LUCYInnovative Eyewear, Inc.
DXRDaxor Corporation
NXGLNEXGEL, Inc.
PDEXPro-Dex, Inc.
NYXHNyxoah S.A.
STSSSharps Technology, Inc.

POAI Ownership FAQ

Predictive Oncology is owned by institutional shareholders (0.00%), insiders (2.16%), and public (97.83%). The largest institutional shareholder of Predictive Oncology is ADVISORNET FINANCIAL, INC (0.00% of total shares) and the top mutual fund owner is T. Rowe Price Index Trust, Inc. (0.01% of total shares).

Predictive Oncology's major institutional shareholders are ADVISORNET FINANCIAL, INC, and CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0.00% of the company's share outstanding.

As of Jun 2024, there are 1 institutional shareholders of Predictive Oncology.

ADVISORNET FINANCIAL, INC owns 95 shares of Predictive Oncology, representing 0.00% of the company's total shares outstanding, valued at $99 (as of Jun 2024).

As of Jun 2024, CORNERSTONE PLANNING GROUP LLC holds 1 shares of Predictive Oncology (POAI), compromising 0% of the company, valued at $1.